Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2017-03-17 | 2017-09-05 | 3121 |
TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2019-12-12 | 2020-01-25 | 101145 |
TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118928 |
TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125458 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Resolved | 2019-10-31 | 2020-07-23 | 97594 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Resolved | 2019-11-28 | 2020-05-01 | 99856 |
TEVA-RANITIDINE | 300MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1522 |
TEVA-RANITIDINE | 300MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1534 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-03-17 | 2017-04-25 | 3124 |
ACT RANITIDINE | 300MG | TABLET | Resolved | 2017-03-17 | 2017-09-19 | 3320 |
TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-04-03 | 2017-10-24 | 5180 |
TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-03 | 2018-02-21 | 5223 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-05-23 | 2017-09-19 | 10889 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2018-03-16 | 2018-07-30 | 43152 |
ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2023-04-28 | 61340 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2020-02-13 | 68577 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-11-22 | 68580 |
TEVA-IRBESARTAN | 300MG | TABLET | Resolved | 2019-07-02 | 2021-09-10 | 88171 |
TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-09-12 | 2019-10-04 | 93656 |
ACT RANITIDINE | 300MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94855 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |